This inventor holds 1 USPTO granted patent. Top assignee: Dingfu Biotarget Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations of Xiaojuan Liu in Tumor Growth Inhibition
Introduction
Xiaojuan Liu is a prominent inventor based in Suzhou, China. She has made significant contributions to the field of immunology, particularly in the development of immunoconjugates that target tumor growth. Her innovative work has the potential to impact cancer treatment significantly.
Latest Patents
Xiaojuan Liu holds a patent for "Immunoconjugates comprising signal regulatory protein alpha." This immunoconjugate is designed to inhibit tumor growth effectively. The patent includes a composition and/or protein mixture that comprises the immunoconjugate. Additionally, it outlines methods for producing the immunoconjugate and its pharmaceutical applications in cancer treatment.
Career Highlights
Xiaojuan Liu is associated with Dingfu Biotarget Co., Ltd., where she continues to advance her research and development efforts. Her work focuses on creating innovative solutions for cancer therapy, showcasing her dedication to improving patient outcomes.
Collaborations
Xiaojuan collaborates with notable colleagues, including Ting Xu and Kai Fu. Their combined expertise enhances the research and development initiatives at Dingfu Biotarget Co., Ltd.
Conclusion
Xiaojuan Liu's contributions to the field of immunology, particularly through her patent on immunoconjugates, highlight her role as an influential inventor in cancer treatment. Her ongoing work promises to bring new hope to patients battling cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile